Latest Publications

Thompson CM, Heintz MM, Rogers SI, Vincent MJ, Haws LC. 2026. Integration of mechanistic and repeat dose toxicity data in the derivation of an oral reference dose for HFPO-DA. Toxicol Sci April 10:kfag045; doi: 10.1093/toxsci/kfag045. Online ahead of print April 10th. PMID: 41968070.

View Abstract

Bond G, Becker RA, Rish W, Ryman JP, Verwiel AH. 2026. Cumulative impact assessment within vulnerable communities: Challenges, opportunities and path forward. J Toxicol Regul Pol. Accepted, April 7, 2026.

BlueRidge Life Sciences Companies